Open access
Jul 2026
Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial
Background Residual major adverse cardiovascular event (MACE) risk persists despite successful prevention of cardiovascular disease (CVD) with statin therapy among people with HIV (PWH). Identifying key biomarkers related to residual cardiovascular risk is critical for PWH. Objectives The objective of the current analy...
S. Grinspoon, C. deFilippi, T. Umbleja et al.
· JACC: Advances · 1 citation